Portfolio Lifecycle Management
Managing the longevity and relevance of medical device and healthcare consumable products, as they move along the lifecycle curve, is a skill. The healthcare environment is ever changing and fast-paced, so to maximise pricing and margin, it’s key to reinvigorate declining product portfolios. It’s what we’re good at, and expert in delivering.
Supply Chain Rationalisation
One invoice, one shipment, once a month – simple and streamlined. Transfer a direct to market product portfolio to us for significant impact on your supply chain and associated costs. We trade with every UK, Irish, German and Austrian hospital and have the infrastructure in place — from logistics to customer services — to ensure we can take your med-tech product portfolio further.
In-market sales teams, sales managers and marketing personnel are an expensive but necessary resource. Typically, they gravitate towards and focus on products that are new, innovative and high margin. We can release their time, so they can fully concentrate on these products whilst we manage your less attractive but still high revenue portfolios.
Guaranteed Revenues & Margin
As a large, financially strong, pan-European company, Healthcare 21 has scale. We have the capability to guarantee our new and existing partners pre-agreed consistent monthly, quarterly or annual orders. This means our partners can benefit from assured, long term revenue streams and margin.
Over many years of partnership, with some of the largest medical device companies in the world, we have built a reputation for both large and small product portfolio transitions. We have extensive experience with the legal, regulatory, contractual and HR processes, including contract novation and TUPE of staff, in the transfer from both direct and in-direct operations.